Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to elucidate the reasons why patients with chronic hepatitis C
(CHC) would not be considered eligible for antiviral treatment. The study is conducted in
common clinical practice at approximately 54 sites in Italy. Patients deemed eligible for
antiviral therapy will be treated at the discretion of the physician with either
peginterferon alfa-2a or peginterferon alfa-2b, both in combination with ribavirin, in
accordance with approved labeling. A secondary objective of this study is to define
"treatment failure" and to evaluate the reasons for treatment discontinuation.